Similarly, Queck et al. showed that ALOX12/15 knockout can exacerbate alcoholic hepatitis, while activation of ALXR/FPR2 using LXA4 can attenuate alcohol-induced hepatic steatosis in ALOX12/15−/− mice [23]. This evidence concerns the gene ALOX12 and fatty liver disease.